Morgan, E. et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72 (2), 338–344 (2023).
Google Scholar
Chung, D. C. et al. A Cell-free DNA Blood-Based test for colorectal Cancer Screening. N Engl. J. Med. 390 (11), 973–983 (2024).
Google Scholar
Xie, Y. H., Chen, Y. X. & Fang, J. Y. Comprehensive review of targeted therapy for colorectal cancer. Signal. Transduct. Target. Ther. 5 (1), 22 (2020).
Google Scholar
Li, L. et al. Comprehensive proteogenomic profiling reveals the molecular characteristics of colorectal Cancer at distinct stages of Progression. Cancer Res. 84 (17), 2888–2910 (2024).
Google Scholar
Shin, A. E., Giancotti, F. G. & Rustgi, A. K. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol. Sci. 44 (4), 222–236 (2023).
Google Scholar
Nunes, L. et al. Prognostic genome and transcriptome signatures in colorectal cancers. Nature 633 (8028), 137–146 (2024).
Google Scholar
Bejarano, L., Jordao, M. J. C. & Joyce, J. A. Therapeutic targeting of the tumor Microenvironment. Cancer Discov. 11 (4), 933–959 (2021).
Google Scholar
Arashi, K. et al. Bilateral deafness due to relapsing polychondritis with semicircular canal calcification treated with cochlear implantation: A case report. Ear Nose Throat J. 1455613231215173. (2023).
Li, Y., Wu, X., Fang, D. & Luo, Y. Informing immunotherapy with multi-omics driven machine learning. NPJ Digit. Med. 7 (1), 67 (2024).
Google Scholar
Mouradov, D. et al. Oncomicrobial community profiling identifies clinicomolecular and prognostic subtypes of colorectal Cancer. Gastroenterology 165 (1), 104–120 (2023).
Google Scholar
Ibeanu, G. C., Rowaiye, A. B., Okoli, J. C. & Eze, D. U. Microbiome differences in colorectal Cancer patients and healthy individuals: implications for vaccine antigen Discovery. Immunotargets Ther. 13, 749–774 (2024).
Google Scholar
Espinosa, E., Bautista, R., Larrosa, R. & Plata, O. Advancements in long-read genome sequencing technologies and algorithms. Genomics 116 (3), 110842 (2024).
Google Scholar
Hu, M. et al. IMOVNN: incomplete multi-omics data integration variational neural networks for gut microbiome disease prediction and biomarker identification. Brief. Bioinform. 24 (6). (2023).
Paczkowska, M. et al. Integrative pathway enrichment analysis of multivariate omics data. Nat. Commun. 11 (1), 735 (2020).
Google Scholar
Langerud, J. et al. Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer. Nat. Commun. 15 (1), 4342 (2024).
Google Scholar
Xu, X. et al. Multi-omics analysis to identify driving factors in colorectal cancer. Epigenomics 12 (18), 1633–1650 (2020).
Google Scholar
Ma, Y. et al. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment. Eur. J. Med. Res. 29 (1), 207 (2024).
Google Scholar
Wang, F. et al. A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer. J. Cancer Res. Clin. Oncol. 150 (3), 124 (2024).
Google Scholar
Stahler, A. et al. Consensus molecular subtypes as biomarkers of fluorouracil and folinic acid maintenance therapy with or without panitumumab in RAS Wild-Type metastatic colorectal Cancer (PanaMa, AIO KRK 0212). J. Clin. Oncol. 41 (16), 2975–2987 (2023).
Google Scholar
Dedecker, L. et al. Microbiome distinctions between the CRC carcinogenic pathways. Gut Microbes. 13 (1), 1854641 (2021).
Google Scholar
Kong, C. et al. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer. Gut 72 (6), 1129–1142 (2023).
Google Scholar
Liu, Z. et al. Multi-Omics analysis reveals intratumor microbes as immunomodulators in colorectal Cancer. Microbiol. Spectr. 11 (2), e0503822 (2023).
Google Scholar
Li, Y. et al. Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies. Cell. Rep. Med. 4 (12), 101311 (2023).
Google Scholar
Deng, F. et al. Performance and efficiency of machine learning algorithms for analyzing rectangular biomedical data. Lab. Invest. 101 (4), 430–441 (2021).
Google Scholar
Chu, G., Ji, X., Wang, Y. & Niu, H. Integrated multiomics analysis and machine learning refine molecular subtypes and prognosis for muscle-invasive urothelial cancer. Mol. Ther. Nucleic Acids. 33, 110–126 (2023).
Google Scholar
Liu, Z. et al. Machine learning-based integration develops an immune-derived LncRNA signature for improving outcomes in colorectal cancer. Nat. Commun. 13 (1), 816 (2022).
Google Scholar
Wang, R. et al. Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients. J. Hematol. Oncol. 15 (1), 11 (2022).
Google Scholar
Reel, P. S. et al. Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study. EBioMedicine 84, 104276 (2022).
Google Scholar
Preto, A. J. et al. Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel disease. J. Crohns Colitis 19 (1). (2025).
Foersch, S. et al. Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer. Nat. Med. 29 (2), 430–439 (2023).
Google Scholar
Wang, X. et al. Epigenetically regulated gene expression profiles reveal four molecular subtypes with prognostic and therapeutic implications in colorectal cancer. Brief. Bioinform. 22 (4). (2021).
Wei, W., Li, Y. & Huang, T. Using machine learning methods to study colorectal cancer tumor micro-environment and its biomarkers. Int. J. Mol. Sci. 24 (13). (2023).
Liu, Z. et al. Integrative analysis from multi-center studies identities a consensus machine learning-derived LncRNA signature for stage II/III colorectal cancer. EBioMedicine 75, 103750 (2022).
Google Scholar
Chen, G. et al. Exploring the gut microbiome’s role in colorectal cancer: diagnostic and prognostic implications. Front. Immunol. 15, 1431747 (2024).
Google Scholar
Du, W., Frankel, T. L., Green, M. & Zou, W. IFNgamma signaling integrity in colorectal cancer immunity and immunotherapy. Cell. Mol. Immunol. 19 (1), 23–32 (2022).
Google Scholar
Zhang, S. et al. Integration of clinical trial Spatial multiomics analysis and virtual clinical trials enables immunotherapy response prediction and biomarker Discovery. Cancer Res. 84 (16), 2734–2748 (2024).
Google Scholar
Carson, T. L. et al. A case-control study of the association between the gut microbiota and colorectal cancer: exploring the roles of diet, stress, and race. Gut Pathog. 16 (1), 13 (2024).
Google Scholar
Sheng, D. et al. Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis. Cancer Lett. 598, 217077 (2024).
Google Scholar
Lu, X. et al. MOVICS: an R package for multi-omics integration and visualization in cancer subtyping. Bioinformatics 36 (22–23), 5539–5541 (2021).
Google Scholar
Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).
Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods. 12 (5), 453–457 (2015).
Google Scholar
Smith, J. J. et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 138 (3), 958–968 (2010).
Google Scholar
Freeman, T. J. et al. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of beta-catenin. Gastroenterology 142 (3), 562–571 (2012). e2.
Google Scholar
Del Rio, M. et al. Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies. Eur. J. Cancer. 76, 68–75 (2017).
Google Scholar
Szeglin, B. C. et al. A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer. Cancer Rep. (Hoboken). 5 (1), e1423 (2022).
Google Scholar
Sturm, G. et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics 35 (14), i436–i445 (2019).
Google Scholar
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A. 102 (43), 15545–15550 (2005).
Google Scholar
Kanehisa, M. et al. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672–D677 (2025).
Google Scholar
Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947–1951 (2019).
Google Scholar
Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27–30 (2000).
Google Scholar
Riaz, N. et al. Tumor and microenvironment evolution during immunotherapy with Nivolumab. Cell 171 (4), 934–949e16 (2017).
Google Scholar
Lauss, M. et al. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nat. Commun. 8 (1), 1738 (2017).
Google Scholar
Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 Blockade in metastatic melanoma. Science 350 (6257), 207–211 (2015).
Google Scholar
Gide, T. N. et al. Distinct immune cell populations define response to Anti-PD-1 monotherapy and Anti-PD-1/Anti-CTLA-4 combined Therapy. Cancer Cell. 35 (2), 238–255e6 (2019).
Google Scholar
Rose, T. L. et al. Fibroblast growth factor receptor 3 alterations and response to immune checkpoint Inhibition in metastatic urothelial cancer: a real world experience. Br. J. Cancer. 125 (9), 1251–1260 (2021).
Google Scholar
Mariathasan, S. et al. TGFbeta attenuates tumour response to PD-L1 Blockade by contributing to exclusion of T cells. Nature 554 (7693), 544–548 (2018).
Google Scholar
Song, M., Chan, A. T. & Sun, J. Influence of the gut microbiome, diet, and environment on risk of colorectal Cancer. Gastroenterology 158 (2), 322–340 (2020).
Google Scholar
Brennan, C. A. & Garrett, W. S. Fusobacterium nucleatum – symbiont, opportunist and oncobacterium. Nat. Rev. Microbiol. 17 (3), 156–166 (2019).
Google Scholar
Huang, Y. et al. Nontoxigenic Bacteroides fragilis: A double-edged sword. Microbiol. Res. 286, 127796 (2024).
Google Scholar
Lopez-Siles, M., Duncan, S. H., Garcia-Gil, L. J. & Martinez-Medina, M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 11 (4), 841–852 (2017).
Google Scholar
Sanders, M. E. et al. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat. Rev. Gastroenterol. Hepatol. 16 (10), 605–616 (2019).
Google Scholar
Wong, S. H. & Yu, J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 16 (11), 690–704 (2019).
Google Scholar
Nicolini, A. & Ferrari, P. Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy. Front. Immunol. 15, 1353787 (2024).
Google Scholar
